HALEON PLC-ADR (HLN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HLN - US4055521003 - ADR
9.52 USD
-0.07 (-0.73%)
9.52 USD
0 (0%)
HLN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. HLN has an excellent profitability rating, but there are some minor concerns on its financial health. HLN is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year HLN was profitable.
In the past year HLN had a positive cash flow from operations.
In the past 5 years HLN has always been profitable.
Each year in the past 5 years HLN had a positive operating cash flow.
1.2 Ratios
HLN has a Return On Assets of 4.20%. This is amongst the best in the industry. HLN outperforms 85.34% of its industry peers.
With an excellent Return On Equity value of 8.92%, HLN belongs to the best of the industry, outperforming 84.29% of the companies in the same industry.
HLN has a Return On Invested Capital of 6.11%. This is amongst the best in the industry. HLN outperforms 83.77% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HLN is significantly below the industry average of 12.85%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROIC | 6.11% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
1.3 Margins
With an excellent Profit Margin value of 12.84%, HLN belongs to the best of the industry, outperforming 85.34% of the companies in the same industry.
HLN's Profit Margin has improved in the last couple of years.
The Operating Margin of HLN (21.31%) is better than 89.01% of its industry peers.
HLN's Operating Margin has improved in the last couple of years.
HLN has a better Gross Margin (60.75%) than 71.20% of its industry peers.
HLN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% |
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HLN is destroying value.
The number of shares outstanding for HLN has been reduced compared to 1 year ago.
HLN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for HLN is higher compared to a year ago.
2.2 Solvency
HLN has an Altman-Z score of 2.26. This is not the best score and indicates that HLN is in the grey zone with still only limited risk for bankruptcy at the moment.
HLN has a Altman-Z score of 2.26. This is in the better half of the industry: HLN outperforms 61.26% of its industry peers.
HLN has a debt to FCF ratio of 5.11. This is a neutral value as HLN would need 5.11 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.11, HLN belongs to the top of the industry, outperforming 82.20% of the companies in the same industry.
A Debt/Equity ratio of 0.53 indicates that HLN is somewhat dependend on debt financing.
HLN has a worse Debt to Equity ratio (0.53) than 64.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Altman-Z | 2.26 |
ROIC/WACC0.75
WACC8.15%
2.3 Liquidity
A Current Ratio of 0.98 indicates that HLN may have some problems paying its short term obligations.
The Current ratio of HLN (0.98) is worse than 84.82% of its industry peers.
HLN has a Quick Ratio of 0.98. This is a bad value and indicates that HLN is not financially healthy enough and could expect problems in meeting its short term obligations.
HLN's Quick ratio of 0.78 is on the low side compared to the rest of the industry. HLN is outperformed by 84.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 6.59% over the past year.
The Earnings Per Share has been growing by 17.56% on average over the past years. This is quite good.
Looking at the last year, HLN shows a decrease in Revenue. The Revenue has decreased by -0.61% in the last year.
The Revenue has been growing slightly by 5.78% on average over the past years.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%
3.2 Future
Based on estimates for the next years, HLN will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.10% on average per year.
HLN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.76% yearly.
EPS Next Y5.7%
EPS Next 2Y8%
EPS Next 3Y8.66%
EPS Next 5Y10.1%
Revenue Next Year-1.32%
Revenue Next 2Y1.63%
Revenue Next 3Y2.58%
Revenue Next 5Y3.76%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 19.43, HLN is valued on the expensive side.
HLN's Price/Earnings ratio is rather cheap when compared to the industry. HLN is cheaper than 81.68% of the companies in the same industry.
When comparing the Price/Earnings ratio of HLN to the average of the S&P500 Index (26.56), we can say HLN is valued slightly cheaper.
With a Price/Forward Earnings ratio of 16.53, HLN is valued correctly.
Based on the Price/Forward Earnings ratio, HLN is valued a bit cheaper than 79.06% of the companies in the same industry.
HLN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.79.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.43 | ||
| Fwd PE | 16.53 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HLN indicates a rather cheap valuation: HLN is cheaper than 81.68% of the companies listed in the same industry.
HLN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HLN is cheaper than 85.34% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.98 | ||
| EV/EBITDA | 14.55 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HLN does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of HLN may justify a higher PE ratio.
PEG (NY)3.41
PEG (5Y)1.11
EPS Next 2Y8%
EPS Next 3Y8.66%
5. Dividend
5.1 Amount
HLN has a Yearly Dividend Yield of 1.88%. Purely for dividend investing, there may be better candidates out there.
HLN's Dividend Yield is rather good when compared to the industry average which is at 0.52. HLN pays more dividend than 92.67% of the companies in the same industry.
HLN's Dividend Yield is comparable with the S&P500 average which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.88% |
5.2 History
HLN has been paying a dividend for at least 10 years, so it has a reliable track record.
HLN has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
39.53% of the earnings are spent on dividend by HLN. This is a low number and sustainable payout ratio.
DP39.53%
EPS Next 2Y8%
EPS Next 3Y8.66%
9.52
-0.07 (-0.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners56.78%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap42.39B
Revenue(TTM)11.23B
Net Income(TTM)1.44B
Analysts79.17
Price Target11.42 (19.96%)
Short Float %0.23%
Short Ratio1.13
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.88% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP39.53%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.58%
Min EPS beat(2)-1.92%
Max EPS beat(2)7.08%
EPS beat(4)3
Avg EPS beat(4)3.76%
Min EPS beat(4)-1.92%
Max EPS beat(4)7.54%
EPS beat(8)4
Avg EPS beat(8)-10.37%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.51%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-3.11%
Min Revenue beat(4)-5.38%
Max Revenue beat(4)-1.64%
Revenue beat(8)1
Avg Revenue beat(8)-2.55%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.09%
PT rev (3m)-3.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.66%
EPS NY rev (1m)0.27%
EPS NY rev (3m)0.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.43 | ||
| Fwd PE | 16.53 | ||
| P/S | 2.82 | ||
| P/FCF | 15.98 | ||
| P/OCF | 13.77 | ||
| P/B | 1.96 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.55 |
EPS(TTM)0.49
EY5.15%
EPS(NY)0.58
Fwd EY6.05%
FCF(TTM)0.6
FCFY6.26%
OCF(TTM)0.69
OCFY7.26%
SpS3.38
BVpS4.86
TBVpS-3.02
PEG (NY)3.41
PEG (5Y)1.11
Graham Number7.32
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROCE | 8.4% | ||
| ROIC | 6.11% | ||
| ROICexc | 6.63% | ||
| ROICexgc | 4145.85% | ||
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% | ||
| FCFM | 17.65% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
ROICexc(3y)6.57%
ROICexc(5y)6.04%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.5%
ROCE(5y)8.01%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y12.56%
ROICexc growth 5Y14.99%
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
F-Score6
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Debt/EBITDA | 3.18 | ||
| Cap/Depr | 98.15% | ||
| Cap/Sales | 2.83% | ||
| Interest Coverage | 6.65 | ||
| Cash Conversion | 84.66% | ||
| Profit Quality | 137.52% | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 | ||
| Altman-Z | 2.26 |
F-Score6
WACC8.15%
ROIC/WACC0.75
Cap/Depr(3y)107.06%
Cap/Depr(5y)107.33%
Cap/Sales(3y)2.94%
Cap/Sales(5y)3.03%
Profit Quality(3y)156.45%
Profit Quality(5y)128.12%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
EPS Next Y5.7%
EPS Next 2Y8%
EPS Next 3Y8.66%
EPS Next 5Y10.1%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%
Revenue Next Year-1.32%
Revenue Next 2Y1.63%
Revenue Next 3Y2.58%
Revenue Next 5Y3.76%
EBIT growth 1Y4.68%
EBIT growth 3Y5.1%
EBIT growth 5Y9.75%
EBIT Next Year11.69%
EBIT Next 3Y8.39%
EBIT Next 5Y7.85%
FCF growth 1Y12.42%
FCF growth 3Y23.3%
FCF growth 5Y29.57%
OCF growth 1Y9.57%
OCF growth 3Y19.28%
OCF growth 5Y23.96%
HALEON PLC-ADR / HLN FAQ
Can you provide the ChartMill fundamental rating for HALEON PLC-ADR?
ChartMill assigns a fundamental rating of 6 / 10 to HLN.
What is the valuation status for HLN stock?
ChartMill assigns a valuation rating of 6 / 10 to HALEON PLC-ADR (HLN). This can be considered as Fairly Valued.
How profitable is HALEON PLC-ADR (HLN) stock?
HALEON PLC-ADR (HLN) has a profitability rating of 8 / 10.
What are the PE and PB ratios of HALEON PLC-ADR (HLN) stock?
The Price/Earnings (PE) ratio for HALEON PLC-ADR (HLN) is 19.43 and the Price/Book (PB) ratio is 1.96.
How financially healthy is HALEON PLC-ADR?
The financial health rating of HALEON PLC-ADR (HLN) is 4 / 10.